Alcohol maker stocks see declines in wake of Surgeon General cancer advisory

Published On Jan 3, 2025, 2:40 PM

Stocks of major alcohol producers such as Molson Coors, Anheuser-Busch InBev, Boston Beer Company, and Brown-Forman saw declines following the U.S. Surgeon General's new advisory that links alcohol consumption with an increased risk of cancer. The advisory highlights that alcohol is the third-leading preventable cause of cancer in the U.S. and suggests reevaluating alcohol consumption limits, as well as adding a cancer warning label on alcoholic beverages. As more consumers become aware of these risks, it could impact sales and profitability for alcohol companies.

Stock Forecasts

BUD

Negative

Given the Surgeon General's advisory on the link between alcohol consumption and cancer, as well as the immediate market reaction showing stock declines, these alcohol maker stocks are likely to continue facing headwinds. The public awareness of health risks associated with alcohol could discourage consumption and affect sales in the long run.

TAP

Negative

With Molson Coors and other producers declining in stock value due to the advisory, it's expected that their stocks will be negatively impacted as consumers reassess their drinking habits. The ongoing conversation around health risks will likely erode confidence in the alcohol sector further, leading to lower stock prices.

SAM

Negative

The Boston Beer Company has seen a significant drop in its stock price in response to the advisory. If the public continues to respond negatively towards alcohol consumption due to health concerns, this trend could worsen for the company in the coming trading sessions.

Related News

There is a new favorite beer on tap. One of Anheuser-Busch InBev's beers nabbed the top spot last month, according to data from Draftline Technologies.

The non-alcoholic beer market has rapidly grown in recent years with some industry experts saying the segment may continue to grow much faster than regular beer.